EU fines US firm Illumina $475 million for jumping gun on buyout of cancer-screening company Grail

  • 📰 AP
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 51%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

The European Union slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the EU's antitrust watchdog. Last year, the EU blocked the $7.1 billion merger on competition grounds.

The Kremlin spokesman says Russia considers plans by G7 nations to offer Ukraine security guarantees “extremely ill-judged and potentially very dangerous.”

Illumina is a major supplier of next-generation sequencing systems for genetic and genomic analysis, while Grail is a health company developing blood tests to try to catch cancer early.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 728. in EG
 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

مصر أحدث الأخبار, مصر عناوين